Logo Marseille Immunology Biocluster
  • About
    +
    • Project presentation
    • MIB’s missions
    • Team and governance
    • Partners
    • Marseille, cradle of immunotherapy
    • Impact (by 2025)
  • Technologies
    +
    • B screen
    • C2iT
    • Cell scale
  • Startup Studio
  • Join us
  • News
  • Contact us
  • FR
  • EN
  • About
    • Project presentation
    • MIB’s missions
    • Team and governance
    • Partners
    • Marseille, cradle of immunotherapy
    • Impact (by 2025)
  • Technologies
    • B screen
    • C2iT
    • Cell scale
  • Startup Studio
  • Join us
  • News
  • Contact us
  • About
    • Project presentation
    • MIB’s missions
    • Team and governance
    • Partners
    • Marseille, cradle of immunotherapy
    • Impact (by 2025)
  • Technologies
    • B screen
    • C2iT
    • Cell scale
  • Startup Studio
  • Join us
  • News
  • Contact us
  • FR
  • EN
Logo Marseille Immunology Biocluster
  • About
    +
    • Project presentation
    • MIB’s missions
    • Team and governance
    • Partners
    • Marseille, cradle of immunotherapy
    • Impact (by 2025)
  • Technologies
    +
    • B screen
    • C2iT
    • Cell scale
  • Startup Studio
  • Join us
  • News
  • Contact us
  • FR
  • EN
  • About
    • Project presentation
    • MIB’s missions
    • Team and governance
    • Partners
    • Marseille, cradle of immunotherapy
    • Impact (by 2025)
  • Technologies
    • B screen
    • C2iT
    • Cell scale
  • Startup Studio
  • Join us
  • News
  • Contact us
  • About
    • Project presentation
    • MIB’s missions
    • Team and governance
    • Partners
    • Marseille, cradle of immunotherapy
    • Impact (by 2025)
  • Technologies
    • B screen
    • C2iT
    • Cell scale
  • Startup Studio
  • Join us
  • News
  • Contact us
  • FR
  • EN

A French-American breakthrough rewrites DNA to defeat cancer

Scientific Innovation

A 36-year-old American patient with stage IV colorectal cancer was facing a critical situation: all conventional treatments had failed. Today, however, she has been in complete remission for nearly two years thanks to her participation in a groundbreaking clinical trial conducted at the prestigious Masonic Cancer Center at the University of Minnesota in Minneapolis. This […]

09.09.2025 / 0 Comments
read more

MIB is supported by a Scientific Advisory Board of Excellence

Press & Media

The Marseille Immunology Biocluster (MIB) is now guided by an International Scientific Advisory Board (SAB), composed of globally recognized scientists known for their expertise and integrity. A shared expertise guiding innovation As an independent body, the SAB ensures the scientific rigor, innovation, and high standards at the core of MIB’s research projects. Chaired by Professor […]

22.07.2025 / 0 Comments
read more

MIB in Shanghai: The strategic role of Clinical Investigation Centers in the evolution of global healthcare

Ecosystem & Events

Lors du DIA China Annual Meeting 2025 à Shanghai, le Dr Daniel Olive (Professeur d’immunologie, praticien hospitalier et responsable médical, scientifique et technique de MIB) a participé à la table ronde d’ouverture aux côtés de représentants de Chine, d’Arabie Saoudite et des États-Unis. ​ Together, they explored the role of clinical investigation centers in the […]

30.05.2025 / 0 Comments
read more

The MIB raises the voice of immunology at the heart of Europe

Ecosystem & Events

Last week in Brussels, the Marseille Immunology Biocluster (MIB) took a major step forward by asserting its presence on the European stage. During a conference dedicated to Europe’s role in life sciences, Denis Bertin, co-founder of the MIB, delivered a powerful message emphasizing the urgency of repositioning immunology as a central pillar of contemporary biomedical […]

16.05.2025 / 0 Comments
read more

Advancing Europe’s leadership in life science

Ecosystem & Events

Innovation in immunology at the heart of the European agenda On June 12, 2025, in Brussels, patient representatives, public decision-makers, industry leaders, researchers, and European representatives will come together within the European Committee of the Regions to discuss sovereignty and competitiveness drivers in healthcare. This high-level European conference, jointly organized by the Marseille Immunology Biocluster […]

16.05.2025 / 0 Comments
read more

Skin Summit 2025: Vitiligo, a Gateway to a New Era in Applied Immunology

Ecosystem & Events

On April 24 and 25, 2025, Eurobiomed – a founding member of MIB – organized the Skin Summit in Antibes, an event that brought together international dermatology experts for two days of rich scientific exchange. This first edition was a great success, driven by inspiring talks and thought-provoking discussions. Vitiligo, a complex autoimmune disease, was […]

30.04.2025 / 0 Comments
read more

MIB: Press kit November 8, 2024

Press & Media

Marseille Immunology Biocluster: working for tomorrow’s immunology for the benefit of patients. EDITOR’S NOTE from Eric Berton,President of Aix Marseille University,Chairman of the A*Midex Foundation With the birth of the Marseille Immunology Biocluster (MIB), a revolution in immunotherapy is now underway in France. MIB is not just a place where advances in immunopharmacology are imagined, […]

12.11.2024 / 0 Comments
read more

Posts pagination

Previous 1 2 3
Logo Marseille Immunology Biocluster
Linkedin
Legal notice        Privacy policy        Crédits
©2024 – Marseille Immunology Biocluster